Heparin Induces Apoptosis in Lymphocytes from B-cell Chronic Lymphocytic Leukemia

Area of Science:

• Immunology
• Oncology
• Biochemistry

Background:

• Glycosaminoglycans, like heparin, modulate immune responses.
• Heparin exhibits antiproliferative and apoptotic effects in various cell types.
• B-chronic lymphocytic leukemia (B-CLL) is characterized by blocked apoptosis due to bcl-2 proto-oncogene expression.

Purpose of the Study:

• To investigate heparin's ability to induce apoptosis in B-CLL lymphocytes.
• To assess the impact of heparin on bcl-2 expression in B-CLL cells.

Main Methods:

• Peripheral blood lymphocytes from 7 B-CLL patients were cultured with varying heparin concentrations.
• Apoptosis was assessed using agarose gel electrophoresis and cytofluorimetric analysis.
• Bcl-2 expression was evaluated via flow cytometry and immunohistochemistry.

Main Results:

• Heparin induced DNA fragmentation, a hallmark of apoptosis, in B-CLL cells (stages III and IV).
• Cytofluorimetric analysis revealed over 50% apoptosis in neoplastic lymphocytes after heparin treatment.
• Heparin significantly reduced bcl-2 expression in B-CLL cells.

Conclusions:

• Heparin demonstrates potential in inhibiting oncogenes and inducing apoptosis.
• Heparin's induction of apoptosis in neoplastic lymphocytes may impact immune system and blood vessel interactions.